BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Arima H. Twenty Years of Research on Cyclodextrin Conjugates with PAMAM Dendrimers. Pharmaceutics 2021;13:697. [PMID: 34064866 DOI: 10.3390/pharmaceutics13050697] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Rahman MU, Bilal M, Shah JA, Kaushik A, Teissedre PL, Kujawska M. CRISPR-Cas9-Based Technology and Its Relevance to Gene Editing in Parkinson's Disease. Pharmaceutics 2022;14:1252. [PMID: 35745824 DOI: 10.3390/pharmaceutics14061252] [Reference Citation Analysis]
2 Sorokina SA, Shifrina ZB. Dendrimers as Antiamyloid Agents. Pharmaceutics 2022;14:760. [DOI: 10.3390/pharmaceutics14040760] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Kheraldine H, Rachid O, Habib AM, Al Moustafa AE, Benter IF, Akhtar S. Emerging innate biological properties of nano-drug delivery systems: A focus on PAMAM dendrimers and their clinical potential. Adv Drug Deliv Rev 2021;178:113908. [PMID: 34390777 DOI: 10.1016/j.addr.2021.113908] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 9.0] [Reference Citation Analysis]